Jubilant HICON - Kit for the Preparation of Sodium Iodide I 131 Capsules and Solution USP Therapeutic – Oral

HICON® is a radioactive therapeutic agent indicated for the treatment of hyperthyroidism and selected cases of carcinoma of the thyroid.¹

The thyroid gland needs iodine to produce its essential hormones that help regulate the body’s metabolism. The hormones the thyroid produces are called T3 (triiodothyronine), T4 (thyroxine), and calcitonin. The thyroid is remarkably efficient in capturing and storing iodine from one’s diet. Radioactive iodine, such as iodine-131, is captured by the thyroid in the same way. However, when iodine-131 accumulates in thyroid cells, it releases radiation that will destroy these cells. This unique ability has made iodine-131 a preferred treatment option for differentiated thyroid cancer (DTC) the most common form of thyroid cancer, and hyperthyroidism.

HICON® is typically used in the following scenarios as part of DTC treatment:

• Ablation—Destroys normal thyroid tissue following surgery
  • Facilitates long-term monitoring of any progression or spread of cancer¹
  • Enhances the effectiveness of future radioiodine treatments, if needed, by allowing delivery of higher doses¹
• Adjunct therapy—Detects and destroys suspected residual disease and distant metastases
  • Minimizes risk of DTC relapse or recurrence
• Treatment of recurrent thyroid cancer